Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Bio-Techne's Exosome Diagnostics laboratory announces contract with Humana » 07:05
03/01/21
03/01
07:05
03/01/21
07:05
TECH

Bio-Techne

$362.00 /

-5.49 (-1.49%)

, HUM

Humana

$379.64 /

-1.3 (-0.34%)

Bio-Techne (TECH)…

Bio-Techne (TECH) announced that Humana (HUM) has awarded a contract effective April 1, to its Exosome Diagnostics laboratory, covering the ExoDx Prostate test for men. Humana is the nation's largest Medicare Advantage provider serving an estimated 20M patients in the United States.

ShowHide Related Items >><<
TECH Bio-Techne
$362.00 /

-5.49 (-1.49%)

HUM Humana
$379.64 /

-1.3 (-0.34%)

TECH Bio-Techne
$362.00 /

-5.49 (-1.49%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
HUM Humana
$379.64 /

-1.3 (-0.34%)

01/13/21 Deutsche Bank
DaVita price target raised to $150 from $105 at Deutsche Bank
01/06/21 Argus
Humana price target raised to $450 from $430 at Argus
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
TECH Bio-Techne
$362.00 /

-5.49 (-1.49%)

HUM Humana
$379.64 /

-1.3 (-0.34%)

HUM Humana
$379.64 /

-1.3 (-0.34%)

HUM Humana
$379.64 /

-1.3 (-0.34%)

Thursday
Conference/Events
Citigroup to hold a virtual conference » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
BIO

Bio-Rad

$594.44 /

+0.09 (+0.02%)

, DGX

Quest Diagnostics

$115.77 /

-1.73 (-1.47%)

, DXCM

DexCom

$405.52 /

-1.49 (-0.37%)

, EXAS

Exact Sciences

$135.04 /

-3.84 (-2.76%)

, HOLX

Hologic

$75.15 /

-0.4 (-0.53%)

, JNJ

Johnson & Johnson

$162.61 /

+2.105 (+1.31%)

, MDT

Medtronic

$118.73 /

+0.71 (+0.60%)

, MTD

Mettler-Toledo

$1,126.92 /

+15.75 (+1.42%)

, PEN

Penumbra

$288.57 /

+8.5 (+3.03%)

, PODD

Insulet

$262.39 /

+1.9 (+0.73%)

, SHC

Sotera Health

$26.72 /

+0.28 (+1.06%)

, SLQT

SelectQuote

$30.76 /

+0.795 (+2.65%)

, TECH

Bio-Techne

$374.73 /

-2.58 (-0.68%)

, TNDM

TNDM

/

+

, ZBH

Zimmer Biomet

$163.78 /

+1.96 (+1.21%)

2021 Healthcare Services,…

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

TNDM TNDM
/

+

TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PODD Insulet
$262.39 /

+1.9 (+0.73%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$405.52 /

-1.49 (-0.37%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.15 /

-0.4 (-0.53%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.73 /

+0.71 (+0.60%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$288.57 /

+8.5 (+3.03%)

02/24/21 Canaccord
Penumbra price target raised to $310 from $204 at Canaccord
02/24/21 Wells Fargo
Penumbra price target raised to $310 from $260 at Wells Fargo
02/24/21 Citi
Penumbra price target raised to $325 from $255 at Citi
12/16/20
Fly Intel: Top five analyst downgrades
PODD Insulet
$262.39 /

+1.9 (+0.73%)

02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

TNDM TNDM
/

+

TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PODD Insulet
$262.39 /

+1.9 (+0.73%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

  • 20
    Nov
  • 28
    May
  • 21
    May
  • 13
    May
PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

Wednesday
Conference/Events
Citigroup to hold a virtual conference » 04:55
02/24/21
02/24
04:55
02/24/21
04:55
BIO

Bio-Rad

$594.35 /

-8.99 (-1.49%)

, DGX

Quest Diagnostics

$117.46 /

+1.24 (+1.07%)

, DXCM

DexCom

$406.68 /

-5.06 (-1.23%)

, EXAS

Exact Sciences

$138.96 /

-3.4 (-2.39%)

, HOLX

Hologic

$75.56 /

+0.96 (+1.29%)

, JNJ

Johnson & Johnson

$160.50 /

-1.265 (-0.78%)

, MDT

Medtronic

$118.01 /

+2.26 (+1.95%)

, MTD

Mettler-Toledo

$1,110.50 /

-24.39 (-2.15%)

, PEN

Penumbra

$280.77 /

+0.9 (+0.32%)

, PODD

Insulet

$261.12 /

+4.25 (+1.65%)

, SHC

Sotera Health

$26.39 /

-0.86 (-3.16%)

, SLQT

SelectQuote

$29.96 /

-0.09 (-0.30%)

, TECH

Bio-Techne

$376.78 /

+0.05 (+0.01%)

, TNDM

TNDM

/

+

, ZBH

Zimmer Biomet

$161.82 /

+1.47 (+0.92%)

2021 Healthcare Services,…

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$406.68 /

-5.06 (-1.23%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.56 /

+0.96 (+1.29%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.01 /

+2.26 (+1.95%)

02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
01/11/21 Piper Sandler
Medtronic updates thoughts on Q3, products, says Piper Sandler
01/07/21 Morgan Stanley
Axonics price target raised to $58 from $53 at Morgan Stanley
MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

12/16/20
Fly Intel: Top five analyst downgrades
12/16/20 Wells Fargo
Penumbra price target lowered to $215 from $265 at Wells Fargo
12/16/20 Canaccord
Penumbra price target lowered to $204 from $292 at Canaccord
12/16/20 Citi
Citi keeps Buy rating on Penumbra, says recall 'clearning event'
PODD Insulet
$261.12 /

+4.25 (+1.65%)

02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
11/05/20 Wells Fargo
Insulet price target raised to $266 from $250 at Wells Fargo
SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

  • 20
    Nov
  • 28
    May
  • 21
    May
  • 13
    May
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

Over a week ago
Conference/Events
Citigroup to hold a virtual conference » 17:49
02/23/21
02/23
17:49
02/23/21
17:49
BIO

Bio-Rad

$594.35 /

-8.99 (-1.49%)

, DGX

Quest Diagnostics

$117.46 /

+1.24 (+1.07%)

, DXCM

DexCom

$406.68 /

-5.06 (-1.23%)

, EXAS

Exact Sciences

$138.96 /

-3.4 (-2.39%)

, HOLX

Hologic

$75.56 /

+0.96 (+1.29%)

, JNJ

Johnson & Johnson

$160.50 /

-1.265 (-0.78%)

, MDT

Medtronic

$118.01 /

+2.26 (+1.95%)

, MTD

Mettler-Toledo

$1,110.50 /

-24.39 (-2.15%)

, PEN

Penumbra

$280.77 /

+0.9 (+0.32%)

, PODD

Insulet

$261.12 /

+4.25 (+1.65%)

, SHC

Sotera Health

$26.39 /

-0.86 (-3.16%)

, SLQT

SelectQuote

$29.96 /

-0.09 (-0.30%)

, TECH

Bio-Techne

$376.78 /

+0.05 (+0.01%)

, TNDM

TNDM

/

+

, ZBH

Zimmer Biomet

$161.82 /

+1.47 (+0.92%)

2021 Healthcare Services,…

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$406.68 /

-5.06 (-1.23%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.56 /

+0.96 (+1.29%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.01 /

+2.26 (+1.95%)

02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
01/11/21 Piper Sandler
Medtronic updates thoughts on Q3, products, says Piper Sandler
01/07/21 Morgan Stanley
Axonics price target raised to $58 from $53 at Morgan Stanley
MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

12/16/20
Fly Intel: Top five analyst downgrades
12/16/20 Wells Fargo
Penumbra price target lowered to $215 from $265 at Wells Fargo
12/16/20 Canaccord
Penumbra price target lowered to $204 from $292 at Canaccord
12/16/20 Citi
Citi keeps Buy rating on Penumbra, says recall 'clearning event'
PODD Insulet
$261.12 /

+4.25 (+1.65%)

02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
11/05/20 Wells Fargo
Insulet price target raised to $266 from $250 at Wells Fargo
SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

  • 20
    Nov
  • 28
    May
  • 21
    May
  • 13
    May
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

Hot Stocks
Bio-Techne, Luminary Therapeutics sign license agreement for us of TcBuster » 07:08
02/23/21
02/23
07:08
02/23/21
07:08
TECH

Bio-Techne

$376.66 /

-13.98 (-3.58%)

Bio-Techne announced the…

Bio-Techne announced the signing of a license agreement with Luminary Therapeutics for the use of TcBuster for the manufacturing of gene-modified cell therapies. TcBuster is Bio-Techne's proprietary non-viral transposon-based gene delivery system used to advance cell therapy manufacturing. Under the terms of this agreement, Bio-Techne grants Luminary Therapeutics a non-exclusive license for TcBuster. Luminary Therapeutics will use TcBuster in their LMY-920 program, a BAFF-CAR-T product. Luminary Therapeutics plans to file an IND with the FDA later this calendar year.

ShowHide Related Items >><<
TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

Upgrade
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance » 07:06
02/23/21
02/23
07:06
02/23/21
07:06
TECH

Bio-Techne

$376.66 /

-13.98 (-3.58%)

As previously reported,…

As previously reported, Stifel analyst Daniel Arias upgraded Bio-Techne to Buy from Hold with a price target of $435, up from $400. The case for "outperformance on the back of top-line excellence looks strong," argues Arias, who thinks the company has several areas of the portfolio that have re-accelerated sharply and also has new drivers that will enter the mix over the next 12 months. He sees the company being "on the verge of being a multi-year 15-20% revenue grower," the analyst added.

ShowHide Related Items >><<
TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
01/12/21 Stifel
Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel
TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

Upgrade
Bio-Techne upgraded to Buy from Hold at Stifel » 05:34
02/23/21
02/23
05:34
02/23/21
05:34
TECH

Bio-Techne

$376.66 /

-13.98 (-3.58%)

Stifel analyst Daniel…

Stifel analyst Daniel Arias upgraded Bio-Techne to Buy from Hold with a $435 price target.

ShowHide Related Items >><<
TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
01/12/21 Stifel
Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel
11/09/20 KeyBanc
Bio-Techne initiated with a Sector Weight at KeyBanc
TECH Bio-Techne
$376.66 /

-13.98 (-3.58%)

Hot Stocks
Kantaro Biosciences signs marketing and distribution agreement with Atrys » 07:35
02/08/21
02/08
07:35
02/08/21
07:35
TECH

Bio-Techne

$380.67 /

-1.81 (-0.47%)

, RNLX

Renalytix AI

$25.80 /

+0.99 (+3.99%)

Kantaro Biosciences, a…

Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI (RNLX), and manufacturing partner Bio-Techne Corporation (TECH), entered into a marketing and distribution agreement with Atrys Health, a biomedical company dedicated to providing diagnostic services and medical treatments of excellence. Atrys Health will offer COVID-SeroKlir and COVID-SeroIndex, Kantaro's quantitative SARS-CoV-2 IgG antibody test kits, in select European and South American territories, including Spain, Portugal, Colombia, Brazil, Peru and Chile. Atrys Health is a distributor for Kantaro quantitative antibody tests in select European and South American territories.The Kantaro tests have received a CE Mark for detecting the presence and precise level of neutralizing IgG antibodies that are produced as part of the immune response to COVID-19 virus exposure.

ShowHide Related Items >><<
TECH Bio-Techne
$380.67 /

-1.81 (-0.47%)

RNLX Renalytix AI
$25.80 /

+0.99 (+3.99%)

TECH Bio-Techne
$380.67 /

-1.81 (-0.47%)

02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
01/12/21 Stifel
Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel
11/09/20 KeyBanc
Bio-Techne initiated with a Sector Weight at KeyBanc
RNLX Renalytix AI
$25.80 /

+0.99 (+3.99%)

08/11/20 JPMorgan
Renalytix AI initiated with a Neutral at JPMorgan
08/11/20 Stifel
Renalytix AI initiated with a Buy at Stifel
TECH Bio-Techne
$380.67 /

-1.81 (-0.47%)

RNLX Renalytix AI
$25.80 /

+0.99 (+3.99%)

  • 17
    Jul
RNLX Renalytix AI
$25.80 /

+0.99 (+3.99%)

Recommendations
Bio-Techne price target raised to $440 from $352 at Craig-Hallum » 08:45
02/03/21
02/03
08:45
02/03/21
08:45
TECH

Bio-Techne

$376.61 /

+35.25 (+10.33%)

Craig-Hallum analyst…

Craig-Hallum analyst Alexander Nowak raised the firm's price target on Bio-Techne to $440 from $352 and keeps a Buy rating on the shares. The analyst notes that the company posted "another impressive quarter," beating the Street's revenue and EPS estimates.

ShowHide Related Items >><<
TECH Bio-Techne
$376.61 /

+35.25 (+10.33%)

TECH Bio-Techne
$376.61 /

+35.25 (+10.33%)

02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
01/12/21 Stifel
Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel
11/09/20 KeyBanc
Bio-Techne initiated with a Sector Weight at KeyBanc
11/06/20 Baird
Bio-Techne price target raised to $320 from $289 at Baird
TECH Bio-Techne
$376.61 /

+35.25 (+10.33%)

Recommendations
Bio-Techne price target raised to $400 from $310 at Citi » 06:24
02/03/21
02/03
06:24
02/03/21
06:24
TECH

Bio-Techne

$376.61 /

+35.25 (+10.33%)

Citi analyst Patrick…

Citi analyst Patrick Donnelly raised the firm's price target on Bio-Techne to $400 from $310 and keeps a Neutral rating on the shares. The company provided a "bullish" near-term outlook on the earnings call, indicating that with the easiest comps of the year upcoming in the second half of fiscal 2021, it should be able to continue its momentum and grow at or above the 15% organic growth posted through the first half, Donnelly tells investors in a research note.

ShowHide Related Items >><<
TECH Bio-Techne
$376.61 /

+35.25 (+10.33%)

TECH Bio-Techne
$376.61 /

+35.25 (+10.33%)

01/12/21 Stifel
Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel
11/09/20 KeyBanc
Bio-Techne initiated with a Sector Weight at KeyBanc
11/06/20 Baird
Bio-Techne price target raised to $320 from $289 at Baird
09/30/20 Atlantic Equities
Bio-Techne initiated with an Overweight at Atlantic Equities
TECH Bio-Techne
$376.61 /

+35.25 (+10.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.